Alemtuzumab as Graft-Versus-Host Disease (GVHD) Prophylaxis Strategy in a Developing Country: Lower Rate of Acute GVHD, Increased Risk of Cytomegalovirus Reactivation
Brazilian Journal of Medical and Biological Research - Brazil
doi 10.1590/1414-431x20165566
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2017
Authors
Publisher
FapUNIFESP (SciELO)